pradeep-xpert commited on
Commit
8302c14
·
verified ·
1 Parent(s): 098dc4c

Upload folder using huggingface_hub

Browse files
Files changed (2) hide show
  1. README.md +210 -0
  2. hc_res_003_sample.csv +0 -0
README.md ADDED
@@ -0,0 +1,210 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ ---
2
+ license: cc-by-nc-4.0
3
+ language:
4
+ - en
5
+ tags:
6
+ - healthcare
7
+ - respiratory
8
+ - pulmonology
9
+ - pneumonia
10
+ - cap
11
+ - hap
12
+ - vap
13
+ - sepsis
14
+ - curb-65
15
+ - psi-score
16
+ - antibiotics
17
+ - synthetic-data
18
+ - ehr
19
+ - clinical
20
+ pretty_name: "HC-RES-003 Pneumonia Synthetic Dataset (Sample)"
21
+ size_categories:
22
+ - n<1K
23
+ task_categories:
24
+ - tabular-classification
25
+ - tabular-regression
26
+ - survival-analysis
27
+ ---
28
+
29
+ # HC-RES-003 — Pneumonia Synthetic Dataset (Sample)
30
+
31
+ **XpertSystems.ai · Synthetic Data Factory · Respiratory Vertical**
32
+
33
+ The third SKU in the XpertSystems **Respiratory** vertical: a clinically detailed synthetic
34
+ pneumonia cohort spanning **Community-Acquired (CAP)**, **Hospital-Acquired (HAP)**,
35
+ **Ventilator-Associated (VAP)**, and **Healthcare-Associated (HCAP)** pneumonia. It covers organism
36
+ taxonomy & resistance (MRSA/MDR), full severity scoring (CURB-65, PSI/Fine, SMART-COP, SOFA,
37
+ APACHE-II, NEWS2, ARDS Berlin), vitals, labs & ABG, respiratory support (HFNC/NIV/IMV/ECMO,
38
+ lung-protective ventilation), guideline-based antibiotic regimens, comorbidities, and
39
+ hospitalization outcomes (ICU, mortality, complications, readmission, cost).
40
+
41
+ This repository contains a **500-row, single-seed sample**. The full commercial product scales to
42
+ 20,000+ patients with CSV / Parquet / JSON delivery.
43
+
44
+ - **SKU:** HC-RES-003
45
+ - **Sample size:** 500 patients × 157 columns
46
+ - **License (sample):** CC-BY-NC-4.0 — commercial license available for the full product
47
+ - **Contact:** pradeep@xpertsystems.ai · https://xpertsystems.ai
48
+
49
+ ---
50
+
51
+ ## Validation
52
+
53
+ This sample passes XpertSystems Grade **A+** validation (overall **10.000 / 10**) with
54
+ deterministic reproduction across all six canonical seeds `[42, 7, 123, 2024, 99, 1]`.
55
+
56
+ Validation philosophy: **structural identities over distribution-fit tests** — including the
57
+ VAP > CAP mortality gradient and the procalcitonin bacterial-vs-viral separation as structural
58
+ floors. This engine also passes its own built-in ~15-check benchmark suite (CAP/HAP/VAP
59
+ distribution, PSI Class-V mortality, CURB-65=0 mortality, ICU/intubation rates, ARDS PF ratio).
60
+
61
+ ### Calibration anchors
62
+
63
+ | Metric | Sample value | Target range | Source |
64
+ |---|---|---|---|
65
+ | CAP prevalence | 67.4% | 60–71% | ATS/IDSA 2019 (~60-70%) |
66
+ | HAP prevalence | 22.0% | 18–28% | Hospital-acquired epidemiology |
67
+ | VAP prevalence | 7.2% | 5–11% | Ventilator-associated epidemiology |
68
+ | ICU admission rate | 21.8% | 15–30% | ATS/IDSA (~18-26%) |
69
+ | Intubation rate | 22.2% | 14–27% | VAP-adjusted |
70
+ | 30-day mortality | ~8.8% | 5–12% | Overall pneumonia mortality |
71
+ | 30-day readmission | ~16.5% | 13–24% | CMS HRRP (~18%) |
72
+ | Median hospital LOS | 4.1 days | 3.5–8 | CAP/HAP LOS literature |
73
+ | **VAP − CAP mortality gradient** | **+0.11** | **≥0.03** | Severity ordering (physiology) |
74
+ | **VAP > CAP mortality holds** | **yes** | **boolean** | Severity ordering |
75
+ | **PCT bacterial / viral ratio** | **23.5×** | **≥3×** | Procalcitonin biomarker separation |
76
+ | **Column count** | **157** | **≥150** | Schema completeness (10 modules) |
77
+
78
+ ---
79
+
80
+ ## Schema highlights by module (157 columns)
81
+
82
+ **Demographics.** Bimodal age (pediatric + adult/elderly), sex, race, insurance, region, nursing-home
83
+ residence, prior 90-day hospitalization.
84
+
85
+ **Classification.** Pneumonia type (CAP/HAP/VAP/HCAP), etiology category, causative organism (type-
86
+ specific taxonomies), MRSA & MDR flags, ICD-10 & SNOMED, chest X-ray finding, procalcitonin, CRP,
87
+ WBC, blood culture, urine antigen, time-to-antibiotics.
88
+
89
+ **Vitals.** Temperature, HR, RR, SBP/DBP/MAP, SpO2, GCS, BMI, plus fever/hypotension/hypoxemia/
90
+ tachypnea flags.
91
+
92
+ **Severity scores.** CURB-65 (+ component flags), PSI/Fine score & risk class, SMART-COP, SOFA (6
93
+ subscores + total), APACHE-II, NEWS2, PF ratio, ARDS Berlin category, sepsis & septic-shock flags,
94
+ ATS major criteria, final severity.
95
+
96
+ **Laboratory.** CBC, neutrophil/lymphocyte ratio, electrolytes, BUN/urea, creatinine, glucose,
97
+ albumin, lactate, D-dimer, ferritin, IL-6, troponin, plus AKI/thrombocytopenia/hyponatremia/
98
+ hyperglycemia flags.
99
+
100
+ **ABG.** FiO2, PaO2, PaCO2, pH, HCO3, lactate, SaO2.
101
+
102
+ **Respiratory support.** O2 delivery device (Room Air → IMV-ECMO), intubation timing, ventilator
103
+ days, lung-protective settings (tidal volume, PEEP, driving/plateau pressure), prone positioning,
104
+ ECMO, NIV, HFNC, spontaneous breathing trial, extubation success, reintubation.
105
+
106
+ **Antibiotics.** Guideline-based empiric regimen, primary & secondary agents (dose/freq/route/
107
+ duration), PCT-guided de-escalation, oral switch, corticosteroids (indication, dexamethasone dose),
108
+ antiviral/antifungal, vasopressors, C. diff, serial procalcitonin.
109
+
110
+ **Comorbidities.** COPD, heart failure, diabetes, CKD, CAD, immunosuppression, HIV, malignancy,
111
+ smoking, alcohol, frailty, vaccinations, aspiration risk.
112
+
113
+ **Outcomes.** ICU admission & LOS, hospital LOS, inpatient/30d/90d mortality, time to death,
114
+ complications (pleural effusion, empyema, AKI, new AF, bacteremia), discharge disposition, 30/90-day
115
+ readmission, time to clinical stability, total cost.
116
+
117
+ ---
118
+
119
+ ## Files
120
+
121
+ - `hc_res_003_sample.csv` — 500-patient sample (157 columns)
122
+ - `generate_sample_dataset_hc_res_003.py` — reproducible generator + validation harness
123
+ - `validation_report.json` / `validation_report.md` — full scorecard
124
+ - `sweep_summary.json` — 6-seed determinism results
125
+
126
+ ## Loading
127
+
128
+ ```python
129
+ import pandas as pd
130
+ df = pd.read_csv("hc_res_003_sample.csv")
131
+ print(df[["patient_id","pneumonia_type","severity_final","curb65_score",
132
+ "psi_risk_class","icu_admission_flag","mortality_30d_flag"]].head())
133
+ ```
134
+
135
+ ```python
136
+ from datasets import load_dataset
137
+ ds = load_dataset("csv", data_files="hc_res_003_sample.csv")
138
+ ```
139
+
140
+ ## Use cases
141
+
142
+ - Pneumonia severity triage (CURB-65 / PSI / SMART-COP score replication & calibration)
143
+ - Mortality and ICU-admission risk prediction
144
+ - Antibiotic-stewardship and PCT-guided de-escalation modeling
145
+ - Bacterial-vs-viral etiology classification from biomarkers
146
+ - ARDS / respiratory-failure progression and ventilation-outcome modeling
147
+ - Readmission-risk and cost modeling
148
+ - ML training where real pneumonia EHR data is PHI-restricted
149
+
150
+ ---
151
+
152
+ ## Honest limitations & disclosed generator behavior
153
+
154
+ This is a strongly calibrated single-table engine (passes its own ~15-check suite; correct severity
155
+ and biomarker gradients). Standard caveats:
156
+
157
+ 1. **Cross-sectional snapshot.** Unlike the asthma (HC-RES-001) and COPD (HC-RES-002) SKUs, this is a
158
+ single admission-level table — there is no longitudinal trajectory or per-event companion table.
159
+ Each row is one pneumonia episode.
160
+ 2. **Severity proxy drives correlated modules.** Vitals, labs, and ABG are generated from a single
161
+ 0–1 severity proxy (seeded by pneumonia type), so they co-move cleanly with severity but encode
162
+ somewhat tighter within-patient coupling than messy real-world data.
163
+ 3. **Some comorbidity/complication flags are marginal draws.** Drawn at fixed (age-adjusted where
164
+ relevant) prevalences rather than jointly conditioned on the full clinical picture.
165
+ 4. **Mortality is a calibrated Bernoulli.** `inpatient_mortality_flag` is drawn on a severity- and
166
+ type-derived probability; time-to-death is an exponential rather than a fully integrated survival
167
+ model. Small CURB-65=0 subsets can show noisy mortality at low n (converges to target at scale).
168
+
169
+ General caveat: cross-field correlations beyond those explicitly modeled may be weaker than in real
170
+ cohorts. **Not for clinical decision-making** — research/development use only.
171
+
172
+ ---
173
+
174
+ ## Commercial product comparison
175
+
176
+ | Capability | This sample | Full HC-RES-003 product |
177
+ |---|---|---|
178
+ | Patients | 500 | 20,000+ (configurable) |
179
+ | Seeds / cohorts | 1 | Multi-seed, reproducible |
180
+ | Formats | CSV | CSV + Parquet + JSON |
181
+ | Comorbidity model | Marginal draws | Jointly conditioned |
182
+ | Mortality | Cross-sectional Bernoulli | Integrated survival model |
183
+ | License | CC-BY-NC-4.0 | Commercial |
184
+ | Support & SLA | — | Included |
185
+
186
+ Full product, custom cohorts, or other respiratory SKUs (asthma, COPD, ILD, pulmonary hypertension,
187
+ sleep apnea): **pradeep@xpertsystems.ai**
188
+
189
+ ---
190
+
191
+ ## Citation
192
+
193
+ ```bibtex
194
+ @dataset{xpertsystems_hc_res_003_2026,
195
+ title = {HC-RES-003: Pneumonia Synthetic Dataset},
196
+ author = {XpertSystems.ai},
197
+ year = {2026},
198
+ publisher = {XpertSystems.ai Synthetic Data Factory},
199
+ url = {https://xpertsystems.ai},
200
+ note = {Synthetic; CC-BY-NC-4.0 (sample). Calibrated to: ATS/IDSA 2019 CAP
201
+ guidelines; PSI/Fine score (Fine et al. 1997, NEJM); CURB-65 (Lim et al.
202
+ 2003, Thorax); SMART-COP (Charles et al. 2008, CID); ARDSNET (NEJM 2000)
203
+ and Berlin ARDS definition; RECOVERY trial (Horby et al. 2021, NEJM); CDC
204
+ NHSN HAP/VAP surveillance; CMS HRRP readmission benchmarks; Surviving Sepsis
205
+ Campaign 2021. Third SKU in the XpertSystems Respiratory vertical.}
206
+ }
207
+ ```
208
+
209
+ *Synthetic data generated by XpertSystems.ai. Not derived from real patient records.
210
+ Not for clinical use.*
hc_res_003_sample.csv ADDED
The diff for this file is too large to render. See raw diff